Jan 13, 2025 · Dupilumab (brand name Dupixent) may be used to treat eczema (atopic dermatitis [AD]), eosinophilic or oral-corticosteroid-dependent asthma, chronic rhinosinusitis with nasal polyps, COPD with an eosinophilic phenotype, eosinophilic esophagitis (EOE), or prurigo nodularis. Dupilumab is self-administered by subcutaneous (under the skin) injection every 1 …

Mar 28, 2023 · Applies to dupilumab: subcutaneous solution. Serious side effects of dupilumab. Along with its needed effects, dupilumab may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention. Check with your doctor immediately if any of the following side effects occur while taking ...

Jan 13, 2025 · Dupixent (dupilumab) may be used to treat eczema (atopic dermatitis [AD]), eosinophilic or oral-corticosteroid-dependent asthma, chronic rhinosinusitis with nasal polyps, COPD with an eosinophilic phenotype, eosinophilic esophagitis (EOE), or prurigo nodularis. Dupixent is self-administered by subcutaneous (under the skin) injection once every 1 to 4 …

Dec 10, 2024 · Dupilumab did not alter immune response to tetanus antigen; immune responses to diphtheria and pertussis antigens not assessed. Vaccines, live. Not known if administration of live vaccines during dupilumab treatment will impact safety or effectiveness of these vaccines. Do not use in patients receiving dupilumab. Warfarin

Mar 25, 2024 · Detailed Dupilumab dosage information for adults and children. Includes dosages for Asthma, Sinusitis, Atopic Dermatitis and more; plus renal, liver and dialysis adjustments.

Oct 10, 2024 · Dupixent (generic name: dupilumab) is approved to treat certain age groups with eczema (atopic dermatitis), asthma, chronic rhinosinusitis (sinus and nasal cavity swelling) with nasal polyps (tissue growths), chronic obstructive pulmonary disease (COPD), eosinophilic esophagitis, and prurigo nodularis (a skin condition). Dupixent works blocking ...

Oct 1, 2024 · Dupixent (dupilumab) is an interleukin-4 receptor alpha antagonist used for the treatment of atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyposis, eosinophilic esophagitis, prurigo nodularis, and chronic obstructive pulmonary disease (COPD).

Mar 25, 2024 · Dupilumab Pregnancy and Breastfeeding Warnings. Brand names: Dupixent. Medically reviewed by Drugs.com. Last updated on Mar 25, 2024. Pregnancy Warnings; Breastfeeding Warnings; Dupilumab Pregnancy Warnings. This drug should be used during pregnancy only if the benefit outweighs the risk to the fetus. AU TGA pregnancy category: B1

TUESDAY, Oct. 1, 2024 -- The U.S. Food and Drug Administration has approved Dupixent (dupilumab) as an add-on maintenance treatment for adults with inadequately controlled chronic obstructive pulmonary disease (COPD) and an eosinophilic phenotype.

Mar 28, 2023 · Dupilumab has an average rating of 7.1 out of 10 from a total of 504 ratings on Drugs.com. 60% of reviewers reported a positive effect, while 21% reported a negative effect. Dupixent has an average rating of 7.1 out of 10 from a total of 480 ratings on Drugs.com. 60% of reviewers reported a positive effect, while 21% reported a negative effect.